Synaquell for Healthy Subjects (HS)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Mayo Clinic in Rochester, Rochester, MN
Healthy Subjects (HS)
Synaquell - DietarySupplement
Eligibility
< 65
All Sexes
What conditions do you have?
Select

Study Summary

This research is being done to investigate the dietary supplement, Synaquell (TM), for effects on brain function in youth ice hockey players.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Healthy Subjects (HS)

Study Objectives

7 Primary · 1 Secondary · Reporting Duration: Baseline, Postseason (approximately 6 months)

Month 6
Change in King-Devick Test (KDT) scores
Change in N100 Amplitude
Change in N100 Latency
Change in N400 Amplitude
Change in N400 Latency
Change in P300 Amplitude
Change in P300 Latency
Change in blood biomarker

Trial Safety

Safety Progress

1 of 3

Other trials for Healthy Subjects (HS)

Trial Design

4 Treatment Groups

Synaquell Male Group
1 of 4
Synaquell Female Group
1 of 4
Placebo Male Group
1 of 4
Placebo Female Group
1 of 4
Experimental Treatment
Non-Treatment Group

150 Total Participants · 4 Treatment Groups

Primary Treatment: Synaquell · Has Placebo Group · N/A

Synaquell Male Group
DietarySupplement
Experimental Group · 1 Intervention: Synaquell · Intervention Types: DietarySupplement
Synaquell Female Group
DietarySupplement
Experimental Group · 1 Intervention: Synaquell · Intervention Types: DietarySupplement
Placebo Male Group
DietarySupplement
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: DietarySupplement
Placebo Female Group
DietarySupplement
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: DietarySupplement

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, postseason (approximately 6 months)

Trial Background

Michael J. Stuart, Principal Investigator
Principal Investigator
Mayo Clinic
Closest Location: Mayo Clinic in Rochester · Rochester, MN
Photo of Rochester  1Photo of Rochester  2Photo of Rochester  3
2021First Recorded Clinical Trial
34 TrialsResearching Healthy Subjects (HS)
502 CompletedClinical Trials

Eligibility Criteria

Age < 65 · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.